![]() |
市場調査レポート
商品コード
1801196
CO2インキュベーターの世界市場 - 市場規模、シェア、動向、予測:製品タイプ別、用途別、容量別、地域別、2025年~2033年Carbon Dioxide Incubators Market Size, Share, Trends, and Forecast by Product Type, Application, Capacity, and Region, 2025-2033 |
||||||
カスタマイズ可能
|
CO2インキュベーターの世界市場 - 市場規模、シェア、動向、予測:製品タイプ別、用途別、容量別、地域別、2025年~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2~3営業日
|
CO2インキュベーターの世界市場規模は、2024年に7億8,053万米ドルとなりました。今後、IMARC Groupは、市場は2033年までに12億5,435万米ドルに達し、2025年から2033年にかけて5.14%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年の市場シェアは34.7%を超えます。市場は、技術進歩、研究開発投資の増加、バイオテクノロジーとライフサイエンス産業の世界的成長に支えられた細胞培養研究、再生医療、医薬品における需要の増加により拡大しています。
世界のCO2インキュベーター市場の成長は、主にバイオテクノロジー、製薬、ライフサイエンス研究における精密な細胞培養環境に対する需要の高まりによってもたらされます。これらのインキュベーターは、幹細胞治療、がん研究、組織工学、再生医療などの用途に不可欠であり、いずれも温度、湿度、CO2レベルを厳密に制御する必要があります。研究開発(R&D)への投資拡大、特に発展途上地域では、コンタミネーションコントロール、自動除染サイクル、遠隔監視機能を備えた先進モデルの採用が加速しています。個別化医療や生物製剤製造へのシフトがCO2インキュベーター市場の成長をさらに後押ししています。これらの分野では、汚染のない信頼性の高い細胞培養を行うために高性能インキュベーターが必要とされているからです。
米国では、旺盛な医薬品研究開発活動、高度な医療インフラ、強力な学術研究能力がCO2インキュベーター市場を牽引しています。同国は幹細胞や腫瘍の研究で世界をリードしており、臨床や研究室での高精度インキュベーターに対する安定した需要を生み出しています。ライフサイエンス分野への政府助成金やCRO(医薬品開発業務受託機関)の利用拡大も市場の需要を支えています。例えば、米国政府は2024年3月、2024年度連結歳出法の一部として全米科学財団の研究関連活動勘定に71億8,000万米ドルを投資し、科学研究を支援すると発表しました。さらに、米国を拠点とする研究所は、スマート技術を統合したインキュベーターをいち早く採用し、信頼性と効率の向上を確保しています。これに加えて、生物製剤、細胞治療、ハイスループットスクリーニングへの継続的な注力は、世界的に重要な市場貢献国としての米国の役割を強化しています。
研究用途の拡大が需要を牽引
世界市場は現在、がん、胚細胞、幹細胞、神経科学、組織工学、哺乳類細胞の培養など、さまざまな研究におけるCO2インキュベーターの用途拡大により成長を遂げています。幹細胞治療市場は2024年に124億米ドルと評価され、2029年には185億米ドルに達すると予測されており、特に再生医療や細胞ベースの治療に関連する研究において、先進的なインキュベーションシステムに対する需要が高まっており、CO2インキュベーター市場の需要を牽引しています。
技術の進歩と医薬品への投資が成長を後押し
主要企業は、製品ポートフォリオを拡大し売上を伸ばすために、先進技術の統合や、自己較正、パスワード保護設定、ドア開放アラーム、自動除染サイクル、事前設定・過熱アラームなどの革新的機能を備えたインキュベーターの導入に注力しており、CO2インキュベーター市場の主要動向の1つとして機能しています。その他の市場開拓要因としては、製薬業界における研究開発活動への支出増加、政府・企業による支援、次世代機器の利用増加などが挙げられます。Press Information Bureauによると、インドの製薬産業は2025年までに1,000億米ドルに達し、年率10~12%で成長すると予想されており、この動向がCO2インキュベーターのような最先端の実験装置の採用を後押ししています。
ライフサイエンスと医薬品研究開発への投資拡大
製薬およびライフサイエンス研究開発の世界の増加が、CO2インキュベーター市場を大きく押し上げています。バイオテクノロジーや創薬プログラムの予算増が、細胞培養、毒性試験、生物製剤開発で使用される信頼性の高いインキュベーションシステムの必要性を高めています。政府や民間団体は、資金提供の増加や戦略的提携によってこの動向を支援しています。インドや中国のような国では、成長する製薬業界が近代的なラボのインフラに多額の投資を行っており、CO2インキュベーターの採用を加速させています。例えば、業界の報告によると、インドの製薬セクターは2000年4月から2024年9月までの間に234億8,000万米ドルの外国直接投資(FDI)を受けており、インドが製薬セクターの強化を推進していることを裏付けています。このような研究開発活動の急増は、高度な実験機器に対する需要を高めるだけでなく、インキュベーターの性能や設計の継続的な革新を促し、CO2インキュベーター市場規模の成長にも寄与しています。
Figure 11 Global: Carbon Dioxide Incubators (Air Jacketed) Market Forecast: Sales Value (in Million USD), 2025-2033
The global carbon dioxide incubators market size was valued at USD 780.53 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 1,254.35 Million by 2033, exhibiting a CAGR of 5.14% from 2025-2033. North America currently dominates the market, holding a market share of over 34.7% in 2024. The market is expanding due to an increasing demand in cell culture research, regenerative medicine, and pharmaceuticals, supported by technological advancements, higher R&D investments, and the global growth of biotechnology and life sciences industries.
The global carbon dioxide incubators market growth is mainly driven by the rising demand for precise cell culture environments in biotechnology, pharmaceutical, and life science research. These incubators are critical for applications such as stem cell therapy, cancer studies, tissue engineering, and regenerative medicine, all of which require tightly controlled temperature, humidity, and CO2 levels. Growing investment in research and development (R&D), especially in developing regions, is accelerating adoption of advanced models featuring contamination control, auto-decontamination cycles, and remote monitoring capabilities. The shift toward personalized medicine and biologics manufacturing further supports carbon dioxide incubators market growth, as these fields depend on high-performance incubators for reliable, contamination-free cell cultivation.
In the United States, the carbon dioxide incubators market is driven by robust pharmaceutical R&D activity, advanced healthcare infrastructure, and strong academic research capabilities. The country leads globally in stem cell and oncology research, generating consistent demand for high-precision incubators in clinical and laboratory settings. Government funding for life sciences and increased use of contract research organizations (CROs) also support carbon dioxide incubators market demand. For instance, in March 2024, the Government of the United States announced a USD 7.18 Billion investment in the National Science Foundation's Research and Related Activities account as part of the FY 2024 Consolidated Appropriations Act, supporting scientific research. Additionally, U.S.-based laboratories are early adopters of incubators with integrated smart technologies, ensuring enhanced reliability and efficiency. Besides this, continued focus on biologics, cell therapy, and high-throughput screening reinforces the country's role as a key market contributor globally.
Expanding Research Applications Driving Demand
The global market is currently experiencing growth on account of the expanding applications of CO2 incubators in different studies, such as cancer, embryonic cell, stem cell, neuroscience, tissue engineering and cultivation of mammalian cells. With the stem cell therapy market valued at USD 12.4 Billion in 2024 and projected to reach USD 18.5 Billion by 2029 as per reports, the demand for advanced incubation systems is rising, especially in research related to regenerative medicine and cell-based therapies, driving the carbon dioxide incubators market demand.
Technological Advancements and Pharmaceutical Investment Boosting Growth
The key players are focusing on the integration of advanced technologies and the introduction of incubators with innovative features, such as self-calibration, password-protected settings, door opening alarms, auto decontamination cycles, and pre-set and over-temperature alarms, to expand their product portfolio and increase their sales, acts as one of a key carbon dioxide incubators market trends. Some of the other factors propelling the growth of the market are the increasing expenditure in the pharmaceutical sector on research and development activities, government and corporate support, and the rising utilization of next-generation equipment. According to the Press Information Bureau, India's pharmaceutical industry is expected to reach USD 100 Billion by 2025, growing at a 10-12% annual rate, a trend that is boosting the adoption of state-of-the-art laboratory equipment like CO2 incubators.
Growing Investment in Life Sciences and Pharmaceutical R&D
The global increase in pharmaceutical and life sciences research and development is significantly boosting the carbon dioxide incubators market. Rising budgets for biotechnology and drug discovery programs are driving the need for reliable incubation systems used in cell culture, toxicity studies, and biologics development. Governments and private organizations are supporting this trend with increased funding and strategic collaborations. In countries like India and China, growing pharmaceutical industries are investing heavily in modern lab infrastructure, accelerating adoption of CO2 incubators. For instance, as per industry reports, the Indian pharmaceutical sector has received US$23.48 Billion in foreign direct investment (FDI) between April 2000 and September 2024, underscoring India's push to elevate pharmaceutical sector. This surge in R&D activity not only raises the demand for advanced lab equipment but also contributes to the growth of the carbon dioxide incubators market size, encouraging continuous innovation in incubator performance and design.
Water jacketed stand as the largest product type in 2024, holding around 37.8% of the market, due to their superior temperature stability and uniform heat distribution. These systems use a heated water layer to maintain consistent internal conditions, making them ideal for sensitive cell culture applications. Their thermal inertia provides extended protection against temperature fluctuations during power outages, which is particularly valuable in long-duration experiments. Water jacketed models are widely adopted in research involving embryonic cells, stem cells, and cancer studies, where even minor environmental deviations can compromise results. Their proven reliability and durability make them a preferred choice for academic, clinical, and pharmaceutical laboratories requiring precise and stable incubation environments for high-quality, reproducible cell culture outcomes.
In virto fertilization leads the market with around 40.7% of carbon dioxide incubators market share in 2024, driven by the rising demand for assisted reproductive technologies worldwide. CO2 incubators play a critical role in maintaining optimal physiological conditions for embryo culture, including precise control of temperature, humidity, and carbon dioxide levels. These conditions are essential for successful fertilization, embryo development, and implantation. As infertility rates rise and awareness of reproductive treatments increases, fertility clinics and specialized hospitals are investing in advanced incubation systems to improve clinical outcomes. Moreover, technological enhancements such as HEPA filtration, real-time monitoring, and low oxygen configurations are further supporting the reliability and success rates of IVF procedures, reinforcing this segment's dominance in the overall market.
Above 200 litre leads the market in 2024, primarily due to its suitability for high-volume research and large-scale cell culture operations. These incubators are widely used in pharmaceutical manufacturing, biotechnology labs, and academic research institutions where multiple samples require simultaneous incubation under controlled conditions. Their larger chamber size supports increased productivity, allowing for higher throughput without compromising environmental stability. Additionally, these units often incorporate advanced features such as programmable controls, contamination prevention systems, and efficient temperature and CO2 regulation, making them ideal for demanding applications like stem cell research, regenerative medicine, and drug development. As research complexity grows and lab workflows expand, demand for high-capacity incubators continues to rise, reinforcing the dominance of this segment in the market.
In 2024, North America accounted for the largest market share of over 34.7%, driven by advanced healthcare infrastructure, high research and development spending, and a strong presence of pharmaceutical and biotechnology companies. The region benefits from robust academic and clinical research activity, particularly in fields such as stem cell therapy, oncology, and regenerative medicine. Regulatory emphasis on product quality and laboratory safety also supports the widespread adoption of advanced CO2 incubators. Additionally, the presence of key market players and early adoption of innovative technologies, including remote monitoring and contamination control systems, further strengthen North America's market position. The growing demand for personalized medicine and biologics continues to drive investment in high-performance incubation systems across research institutions and clinical laboratories.
United States Carbon Dioxide Incubators Market Analysis
In 2024, United States accounted for 85.80% of the market share in North America. The United States carbon dioxide incubators market is experiencing significant growth, driven by advancements in biotechnology, pharmaceuticals, and clinical research. These incubators are essential for cell culture applications, providing precise temperature, humidity, and CO2 levels necessary for biological research, drug development, and in vitro fertilization (IVF). The rising demand for regenerative medicine, cancer research, and stem cell therapy is fueling market expansion. Additionally, increasing investments in biopharmaceutical R&D and the growing number of research laboratories are boosting the adoption of CO2 incubators. For instance, the Department's Economic Development Administration (EDA) states that USD 3.9 Million is invested in the state of North Carolina for infrastructure improvements needed to support the biotechnology and healthcare sectors. Technological advancements, such as automated monitoring systems and contamination control features, further enhance product efficiency and reliability. Moreover, stringent regulatory standards set by agencies like the FDA and CDC are encouraging laboratories to adopt high-performance incubators to ensure compliance. Leading manufacturers are focusing on energy-efficient and innovative models, catering to the increasing demand for sustainable lab solutions.
Europe Carbon Dioxide Incubators Market Analysis
The Europe carbon dioxide incubators market is experiencing steady growth, driven by the increasing focus on life sciences research, regenerative medicine, and clinical trials. Carbon dioxide incubators are essential for cell culture applications, particularly in drug development, microbiology, and cancer research. The rising government and private sector investments in biotechnology and pharmaceutical research are contributing to market expansion. For instance, according to the UK Bioindustry Association, the UK biotech sector secured an impressive £808 Million in Q3 2024, reflecting the growing emphasis on advanced research and development activities. Additionally, the demand for incubators with automated monitoring systems and contamination control technologies is increasing as laboratories seek more efficient and reliable equipment. The growing focus on stem cell research and vaccine development is further supporting market growth. With continuous technological advancements and expanding research infrastructure, the carbon dioxide incubators market in Europe is expected to maintain steady growth in the coming years.
Asia Pacific Carbon Dioxide Incubators Market Analysis
The Asia Pacific carbon dioxide incubators market is growing at a significant pace, driven by rising investments in biotechnology, pharmaceuticals, and academic research. The increasing demand for cell culture applications in drug discovery and regenerative medicine is fueling the adoption of carbon dioxide incubators. Countries are witnessing rapid growth in biomedical research activities, further supporting market expansion. Additionally, the escalating awareness about personalized medicine and cell-based therapies is driving demand for advanced incubator systems. Market players are introducing incubators with precise temperature and humidity controls to cater to the region's expanding research infrastructure. According to the India Brand Equity Foundation, significant contributions to the bioeconomy and the global acceptance of biosimilar products are expected to drive the market to nearly USD 63 Billion by 2025, indicating a promising trajectory. With the continuous growth of the life sciences sector and technological advancements, the Asia Pacific carbon dioxide incubators market is expected to experience steady expansion in the coming years.
Latin America Carbon Dioxide Incubators Market Analysis
The Latin America carbon dioxide incubators market is witnessing moderate growth, driven by increasing investments in biotechnology and pharmaceutical research. Carbon dioxide incubators are widely used in cell culture studies, microbiology, and drug development applications. The rising number of research institutions and clinical laboratories is supporting market expansion. Additionally, the growing focus on disease research and vaccine development is increasing the adoption of advanced incubator systems. According to IMARC Group, Mexico's vaccine market size reached USD 1.1 Billion in 2024 and is projected to reach USD 1.9 Billion by 2033, exhibiting a CAGR of 5.3% during 2025-2033. This rising demand for vaccines is further driving the need for high-quality carbon dioxide incubators in laboratories. Market players are offering incubators with energy-efficient features and contamination control technologies to meet laboratory requirements.
Middle East and Africa Carbon Dioxide Incubators Market Analysis
The Middle East and Africa carbon dioxide incubator market is expanding due to increased investments in biomedical research and healthcare infrastructure, used in clinical laboratories, pharmaceutical research, and microbiology for controlled cell culture studies. The region's growing focus on disease diagnosis, vaccine research, and stem cell studies is boosting demand for advanced incubator systems. According to the Department of Health, the Abu Dhabi Health Department and the Authority of Social Contribution awarded over AED 19 Million (USD 5.17 Million) in grants through the Healthcare Research and Innovation Fund to support advancements in cell and gene therapies, precision medicine, and advanced cancer treatments. This initiative is fostering the adoption of cutting-edge technologies, including carbon dioxide incubators, in biomedical research.
The carbon dioxide incubators market is competitive, with key players focusing on technological innovation, product reliability, and global expansion. Companies are introducing advanced models featuring HEPA filtration, auto-decontamination, and real-time monitoring to address the growing demand for contamination control and regulatory compliance. For instance, in June 2024, Vaisala announced the launch of the GMP80P, a portable CO2 probe with pump sampling, designed for life science incubators. It enables fast, accurate measurements without opening the incubator, ensuring stable conditions and preventing contamination during spot checks or routine monitoring. Moreover, strategic partnerships, mergers, and acquisitions are common as firms seek to expand their product portfolios and strengthen market presence. Leading manufacturers are also investing in energy-efficient and user-friendly designs to meet evolving laboratory needs. Additionally, the increasing focus on life sciences and biotechnology research in emerging markets is contributing to the positive carbon dioxide incubators market outlook, presenting new growth opportunities for both global and regional players.